ACTRN12607000383460已完成不适用
Emergency Management of Moderate Asthma with inhaled ipratropium bromide in children - a comparison of admission rates
Dr Emma Wyatt0 个研究点目标入组 346 人开始时间: 2007年7月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 346
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 2 Years 至 15 Years（—）
- 性别
- All
入选标准
- •Children with an acute exacerbation of asthma of moderate severity (ie one or more of SaO2 90-94%, speaking in phrases, moderate to loud wheeze)
排除标准
- •Children less than 2 years or after 16th birthdaychronic respiratory problemwheeze better accounted for by another diagnosisuse of ipratropium bromide in last 6 hoursmarkers of severity (SaO2 less than 90%, cyanosis, unable to speak, silent chest, abnormal conscious state).
研究者
相似试验
已完成
4 期
The management of non-eosinophilic asthma: a randomised controlled trialAsthmaACTRN12606000488505niversity of Otago, Dunedin, New Zealand33
尚未招募
不适用
Asthma Review and Management in Community PharmacyACTRN12622001176752Medical Research Institute of New Zealand25
尚未招募
不适用
Asthma Management in CHildren Based on Exhaled Nitric Oxide - Randomised Controlled TrialAsthmaRespiratory - AsthmaACTRN12605000321640Royal Children's Hospital110
已完成
不适用
Inhaler instruction in patients with asthma or COPD: can it be improved?asthma and COPDobstructive pulmonary diseases10006436NL-OMON42356ongziekten Martini Ziekenhuis100
尚未招募
不适用
The safety evaluation of severe asthma treated with Mepolizumab in KoreaKCT0006374Hanyang University Seoul Hospital50